IONS vs KMB · rev $514.0M vs P/E 19, rev $8.35B
Ionis Pharmaceuticals Inc (IONS) versus Kimberly-Clark Corporation (KMB) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported KMB revenue for 2026-06-30 was $8.35B. Net income was $1.01B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
IONS currently screens at market cap $12.28B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Not investment advice. Open the IONS and KMB stock pages for the full models.
Not investment advice.